Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

During the Trading Day
1.88 +0.02 / +1.08%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.84 -0.04 / -2.13%
 
Volume: 2.0K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues1.1M7.4M2.7M3.7M
 
 
 
 
 
Cost of Goods Sold702.0K3.2M805.0K1.0M
 
 
 
 
 
Depreciation And Amortization850.0K828.0K800.0K790.0K
 
 
 
 
 
 
Operating ExpensesGross Income-430.0K3.3M1.1M1.9M
 
 
 
 
 
General Expenses12.2M11.9M8.6M10.1M
 
 
 
 
 
Research And Development9.8M8.2M7.1M8.1M
 
 
 
 
 
Total Operating Expenses13.7M15.9M10.2M11.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.6M-8.6M-7.6M-8.2M
 
 
 
 
 
Interest Expense On Debt737.0K915.0K874.0K938.0K
 
 
 
 
 
Other Expenses2.4M2.1M2.1M1.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.9M-7.3M-6.1M-8.0M
 
 
 
 
 
Net Income-10.9M-7.3M-6.1M-8.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS90.7M92.7M92.8M93.0M
 
 
 
 
 
Shares To Calculate EPS Diluted90.7M92.7M92.8M93.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.08-$0.07-$0.09
 
 
 
 
 
EPS Diluted-$0.12-$0.08-$0.07-$0.09
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account